Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Oct;58(10):2071-2081.
doi: 10.1194/jlr.D077990. Epub 2017 Jul 10.

Compound-specific isotope analysis resolves the dietary origin of docosahexaenoic acid in the mouse brain

Affiliations

Compound-specific isotope analysis resolves the dietary origin of docosahexaenoic acid in the mouse brain

R J Scott Lacombe et al. J Lipid Res. 2017 Oct.

Abstract

DHA (22:6n-3) may be derived from two dietary sources, preformed dietary DHA or through synthesis from α-linolenic acid (ALA; 18:3n-3). However, conventional methods cannot distinguish between DHA derived from either source without the use of costly labeled tracers. In the present study, we demonstrate the proof-of-concept that compound-specific isotope analysis (CSIA) by GC-isotope ratio mass spectrometry (IRMS) can differentiate between sources of brain DHA based on differences in natural 13C enrichment. Mice were fed diets containing either purified ALA or DHA as the sole n-3 PUFA. Extracted lipids were analyzed by CSIA for natural abundance 13C enrichment. Brain DHA from DHA-fed mice was significantly more enriched (-23.32‰ to -21.92‰) compared with mice on the ALA diet (-28.25‰ to -27.49‰). The measured 13C enrichment of brain DHA closely resembled the dietary n-3 PUFA source, -21.86‰ and -28.22‰ for DHA and ALA, respectively. The dietary effect on DHA 13C enrichment was similar in liver and blood fractions. Our results demonstrate the effectiveness of CSIA, at natural 13C enrichment, to differentiate between the incorporation of preformed or synthesized DHA into the brain and other tissues without the need for tracers.

Keywords: fatty acid; omega-3 fatty acids; stable isotope analysis.

PubMed Disclaimer

Conflict of interest statement

R.P.B. holds a Canada Research Chair in Brain Lipid Metabolism and has received research grants from Bunge Ltd., Arctic Nutrition, the Dairy Farmers of Canada, and Nestle Inc., as well as travel support from Mead Johnson and mass spectrometry equipment and support from Sciex. R.P.B. is on the executive committee of the International Society for the Study of Fatty Acids and Lipids and held a meeting on behalf of Fatty Acids and Cell Signaling, both of which rely on corporate sponsorship. R.P.B. has given expert testimony in relation to supplements and the brain. R.P.B. also provides complementary FA analysis for farmers, food producers, and others involved in the food industry, some of whom provide free food samples. V.G. holds a Canadian Institutes of Health Research Canada Graduate Scholarship.

Figures

Fig. 1.
Fig. 1.
GC-IRMS trace of FAMEs derived from a mouse brain total lipid extract. The upper plot shows the signal ratio for m/z 45/44. The lower plot shows the signal for m/z 45 for the duration of the IRMS run. The exploded peak (A) highlights the complete baseline resolution of DHA from surrounding peaks. “STD” indicates signal peaks from the admitted calibrating CO2 reference gas; >10 pulses of calibrant were admitted prior to each run.
Fig. 2.
Fig. 2.
Multipoint normalization curve for the reporting of true δ13C values for GC-IRMS data. FAME (20-carbon) certified reference materials, USGS70, USGS71, and USGS72, were injected periodically during each programmed sequence, totaling at least three injections per run.
Fig. 3.
Fig. 3.
DHA tissue concentrations of mice maintained on purified n-3 PUFA-containing diets over multiple generations. DHA concentrations were consistently higher in brain (A), liver (B), serum (C), and RBCs (D) of mice maintained on the DHA diet. All data are mean ± SD (n = 5–6 per group). Data were compared by two-way ANOVA for the interaction of diet and generation; results are presented within each figure. The dashed line represents the mean DHA concentrations of baseline mice; the gray band indicates SD.
Fig. 4.
Fig. 4.
ARA tissue concentrations of mice maintained on purified n-3 PUFA-containing diets over multiple generations. ARA concentrations were consistently lower in brain (A), liver (B), serum (C), and RBCs (D) of mice maintained on the DHA diet. All data are mean ± SD (n = 5–6 per group). Data were compared by two-way ANOVA for the interaction of diet and generation; results are presented within each figure. The dashed line represents the mean ARA concentrations of baseline mice; the gray band indicates SD.
Fig. 5.
Fig. 5.
DHA carbon isotope signatures of mice maintained on purified n-3 PUFA-containing diets over multiple generations. Brain (A), liver (B), serum (C), and RBC (D) δ13CDHAs were more isotopically enriched in the DHA-fed animals when compared with the ALA-fed group across all tissues. Each data point represents one animal; solid and dashed lines indicate the mean values for DHA and ALA diets, respectively (n = 5–6 per group). Data were compared by two-way ANOVA for the interaction of diet and generation; results are presented within each figure. A Bonferroni multiple-comparisons test was conducted following a significant (P < 0.05) interaction. aA significant difference between diet groups within a generation. #A significant difference between generation on the same diet. The upper and lower dotted lines indicate the δ13C signature of dietary DHA and ALA, respectively. The dashed line represents the δ13C of baseline animals; the gray band indicates ±SD.
Fig. 6.
Fig. 6.
ARA carbon isotope signatures of mice maintained on purified n-3 PUFA-containing diets over multiple generations. Brain (A), liver (B), serum (C), and RBC (D) δ13CARAs were found to be similar between dietary groups. Serum δ13CARA was more enriched in mice fed the DHA diet. Each data point represents one animal; solid and dashed lines indicate the mean values for DHA and ALA diets, respectively (n = 5–6 per group). Data were compared by two-way ANOVA for the interaction of diet and generation; results are presented within each figure. A Bonferonni multiple-comparisons test was conducted following a significant (P < 0.05) interaction. aA significant difference between diet groups within a generation. The dotted line indicates the δ13C signature of dietary LNA. The dashed line represents the δ13C of baseline animals; the gray band indicates ±SD.
Fig. 7.
Fig. 7.
Carbon isotopic discrimination factors calculated for brain DHA and ARA. Data show the enrichment of ARA and DHA derived from 18-carbon precursors over dietary signatures. Each data point represents one animal; solid and dashed lines indicate the mean values for DHA and ALA diets, respectively (n = 5–6 per group). Data were compared by two-way ANOVA for the interaction of diet and generation; results are presented within each figure. A Bonferroni multiple-comparisons test was conducted following a significant (P < 0.05) interaction. aA significant difference between diet groups within a generation. #A significant difference between generation on the same diet.

References

    1. Martinez M. 1992. Abnormal profiles of polyunsaturated fatty acids in the brain, liver, kidney and retina of patients with peroxisomal disorders. Brain Res. 583: 171–182. - PubMed
    1. Taha A. Y., Cheon Y., Ma K., Rapoport S. I., and Rao J. S.. 2013. Altered fatty acid concentrations in prefrontal cortex of schizophrenic patients. J. Psychiatr. Res. 47: 636–643. - PMC - PubMed
    1. Bazinet R. P., and Layé S.. 2014. Polyunsaturated fatty acids and their metabolites in brain function and disease. Nat. Rev. Neurosci. 15: 771–785. - PubMed
    1. Liu J. J., Green P., John Mann J., Rapoport S. I., and Sublette M. E.. 2015. Pathways of polyunsaturated fatty acid utilization: implications for brain function in neuropsychiatric health and disease. Brain Res. 1597: 220–246. - PMC - PubMed
    1. Kim H. Y. 2007. Novel metabolism of docosahexaenoic acid in neural cells. J. Biol. Chem. 282: 18661–18665. - PubMed

Publication types